VIRAZOLE's POTENTIAL IS INFECTIOUS IN INVESTMENT COMMUNITY: VIRATEK's MARKET VALUATION SOARS AS HIGH AS $550 MIL. ON PERFORMANCE OF $15 MIL. DRUG